tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

DE:6XP Stock Latest News

Xspray Pharma Wins FDA Review Slot for Dasynoc Ahead of Planned 2026 Dual Launch
Company AnnouncementsXspray Pharma Wins FDA Review Slot for Dasynoc Ahead of Planned 2026 Dual Launch
11d ago
Xspray Pharma Resubmits FDA Application for Leukemia Drug Dasynoc
PremiumCompany Announcements
Xspray Pharma Resubmits FDA Application for Leukemia Drug Dasynoc
24d ago
Xspray Pharma installs new CEO as it pivots to commercial growth
PremiumCompany Announcements
Xspray Pharma installs new CEO as it pivots to commercial growth
25d ago
Xspray Pharma Narrows 2025 Loss as FDA Sets Review Date for XS003
PremiumCompany Announcements
Xspray Pharma Narrows 2025 Loss as FDA Sets Review Date for XS003
1M ago
Xspray Pharma Achieves Key Milestones in Q3 2025
PremiumCompany Announcements
Xspray Pharma Achieves Key Milestones in Q3 2025
5M ago
Xspray Pharma’s XS003 NDA Accepted by FDA with PDUFA Date Set
PremiumCompany AnnouncementsXspray Pharma’s XS003 NDA Accepted by FDA with PDUFA Date Set
5M ago
Xspray Pharma Announces Nomination Committee for 2026 AGM
Premium
Company Announcements
Xspray Pharma Announces Nomination Committee for 2026 AGM
5M ago
Xspray Pharma Faces FDA Approval Delay for Dasynoc Due to Manufacturing Issues
Premium
Company Announcements
Xspray Pharma Faces FDA Approval Delay for Dasynoc Due to Manufacturing Issues
6M ago
Xspray Pharma Expands Share Base Amid High Investor Interest
PremiumCompany Announcements
Xspray Pharma Expands Share Base Amid High Investor Interest
6M ago
Xspray Pharma’s Rights Issue Oversubscribed, Secures SEK 161 Million
PremiumCompany Announcements
Xspray Pharma’s Rights Issue Oversubscribed, Secures SEK 161 Million
6M ago
Xspray Pharma Adjusts Rights Issue Trading Schedule
PremiumCompany Announcements
Xspray Pharma Adjusts Rights Issue Trading Schedule
7M ago
Xspray Pharma Secures Additional SEK 20 Million in Rights Issue
PremiumCompany Announcements
Xspray Pharma Secures Additional SEK 20 Million in Rights Issue
7M ago
Xspray Pharma Announces SEK 130 Million Rights Issue
PremiumCompany AnnouncementsXspray Pharma Announces SEK 130 Million Rights Issue
7M ago
Xspray Pharma’s Nilotinib Study Completion: Market Implications and Insights
Premium
Company Announcements
Xspray Pharma’s Nilotinib Study Completion: Market Implications and Insights
7M ago
6XP
Xspray Pharma AB Completes Key Bioavailability Study for XS003
Premium
Company Announcements
Xspray Pharma AB Completes Key Bioavailability Study for XS003
7M ago
6XP
Xspray Pharma Advances Cancer Treatment with FDA Submission for XS003
PremiumCompany Announcements
Xspray Pharma Advances Cancer Treatment with FDA Submission for XS003
7M ago
Xspray Pharma Advances Towards U.S. Market with Dasynoc®
PremiumCompany Announcements
Xspray Pharma Advances Towards U.S. Market with Dasynoc®
7M ago
Xspray Pharma Announces SEK 130 Million Rights Issue and Loan Refinancing
PremiumCompany Announcements
Xspray Pharma Announces SEK 130 Million Rights Issue and Loan Refinancing
7M ago
Xspray Pharma Licenses Dasatinib Product to Handa Therapeutics
PremiumCompany Announcements
Xspray Pharma Licenses Dasatinib Product to Handa Therapeutics
7M ago
Xspray Pharma Achieves Key Milestone with XS003 Bioequivalence
PremiumCompany AnnouncementsXspray Pharma Achieves Key Milestone with XS003 Bioequivalence
8M ago
Xspray Pharma Achieves Key FDA Milestone for Dasynoc
Premium
Company Announcements
Xspray Pharma Achieves Key FDA Milestone for Dasynoc
9M ago
FDA Sets PDUFA Date for Xspray Pharma’s Dasynoc® Application
Premium
Company Announcements
FDA Sets PDUFA Date for Xspray Pharma’s Dasynoc® Application
10M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >